Markets:

Overview

News

Currencies

International

Treasuries

TG Therapeutics, Inc. - Common Stock (NQ:TGTX)

31.95 +1.50 (+4.93%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about TG Therapeutics, Inc. - Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

TGTX FRIDAY DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages TG Therapeutics, Inc. Investors With Losses to Secure Counsel Before Important September 16 Deadline in Securities Class Action - TGTX

September 11, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages TG Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TGTX

August 27, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

TG Therapeutics Touts Encouraging Data From Multiple Sclerosis Candidate ↗

August 25, 2022

Via Benzinga

NASDAQ:TGTX Investor Alert: Lawsuit Alleges Securities Laws Violations by TG Therapeutics, Inc. ↗

August 17, 2022

San Diego, CA -- (SBWIRE) -- 08/17/2022 -- An investor, who purchased shares of TG Therapeutics, Inc. (NASDAQ:TGTX), filed a lawsuit in the over alleged violations of Federal Securities Laws by TG...

Via SBWire

TOP RANKED ROSEN LAW FIRM Encourages TG Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - TGTX

August 12, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

5 Analysts Have This to Say About TG Therapeutics ↗

June 13, 2022

Analysts have provided the following ratings for TG Therapeutics (NASDAQ:TGTX) within the last quarter:

Via Benzinga

Why Karuna Therapeutics Jumped Around 72%; Here Are 96 Biggest Movers From Yesterday ↗

August 09, 2022

Gainers Helbiz, Inc. (NASDAQ: HLBZ) jumped 114.6% to close at $1.61 on Monday after climbing over 27% on Friday.

Via Benzinga

Why CinCor Pharma Is Trading Higher By 63%, Here Are 79 Stocks Moving In Monday's Mid-Day Session ↗

August 08, 2022

Gainers Bonso Electronics International Inc. (NASDAQ: BNSO) shares jumped 132% to $11.12 after jumping around 46% on Friday. The company recently said it expects unaudited comprehensive loss of $1.6...

Via Benzinga

ROSEN, A LEADING LAW FIRM, Encourages TG Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - TGTX

August 07, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

August 02, 2022

Gainers Applied DNA Sciences (NASDAQ:APDN) stock rose 90.0% to $5.32 during Tuesday's after-market session. At the close, Applied DNA Sciences's trading volume reached 28.8 million shares. This is...

Via Benzinga

TGTX Shareholder News: Robbins LLP is Investigating TG Therapeutics, Inc. (TGTX) on Behalf of Shareholders

August 01, 2022

From Robbins LLP

Via Business Wire

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages TG Therapeutics, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action - TGTX

July 31, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

Bronstein, Gewirtz & Grossman, LLC Notifies TG Therapeutics, Inc. (TGTX) Investors of Class Action and Encourages Investors to Contact the Firm

July 27, 2022

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

ROSEN, A LEADING LAW FIRM, Encourages TG Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TGTX

July 24, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

TGTX Shareholder Alert: Robbins LLP Reminds Investors of Class Action Against TG Therapeutics, Inc. (TGTX)

July 22, 2022

From Robbins LLP

Via Business Wire

Shareholder Alert: Robbins LLP Informs Investors of Class Action Against TG Therapeutics, Inc. (TGTX)

July 20, 2022

From Robbins LLP

Via Business Wire

TG THERAPEUTICS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against TG Therapeutics, Inc. and Encourages Investors to Contact the Firm

July 19, 2022

From Bragar Eagel & Squire, P.C.

Via Business Wire

INVESTOR ACTON ALERT: The Schall Law Firm Encourages Investors in TG Therapeutics, Inc. with Losses of $100,000 to Contact the Firm

July 19, 2022

From The Schall Law Firm

Via Business Wire

SHAREHOLDER ACTON NOTICE: The Schall Law Firm Encourages Investors in TG Therapeutics, Inc. with Losses of $100,000 to Contact the Firm

July 18, 2022

From The Schall Law Firm

Via Business Wire

EQUITY ALERT: Rosen Law Firm Encourages TG Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – TGTX

July 18, 2022

From The Rosen Law Firm, P.A.

Via Business Wire

83 Biggest Movers From Yesterday ↗

June 09, 2022

Gainers Symbotic Inc. (NASDAQ: SYM) shares surged 120.6% to settle at $20.07 on Wednesday. Symbotic reported the completion of its business combination with SVF Investment Corp. to become a publicly...

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

June 01, 2022

On Wednesday, 73 stocks hit new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

May 31, 2022

Via Benzinga

77 Biggest Movers From Yesterday ↗

June 01, 2022

Gainers TherapeuticsMD, Inc. (NASDAQ: TXMD) shares climbed 364% to close at $9.93 on Tuesday after the company announced it has entered into a definitive merger agreement to be acquired by an affiliate...

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

May 25, 2022

On Wednesday, 215 companies set new 52-week lows.

Via Benzinga

Peering Into TG Therapeutics's Recent Short Interest ↗

May 20, 2022

TG Therapeutics's (NASDAQ:TGTX) short percent of float has fallen 8.05% since its last report. The company recently reported that it has 19.37 million shares sold short, which is...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

May 20, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 20, 2022 ↗

May 20, 2022

Upgrades

Via Benzinga

What 4 Analyst Ratings Have To Say About TG Therapeutics ↗

May 20, 2022

Over the past 3 months, 4 analysts have published their opinion on TG Therapeutics (NASDAQ:TGTX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...

Via Benzinga

9 Health Care Stocks With Whale Alerts In Today's Session ↗

May 06, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

TG Therapeutics, Inc. - Common Stock (NQ:TGTX)

All News about TG Therapeutics, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today